The sales mix was not altered significantly. Private Pharma sales represented 83.27% of total sales, Government Pharma accounted for 3.46%, Health, Beauty, Consumer Goods, General Merchandise and Others totaled 9.33% and Publications the remaining 3.94%.
SALES BY DIVISION:
Sales in the Private Pharma division declined marginally, by 0.13%, as a result of the competitive environment that GCS faced in the marketplace, which had an unfavorable impact on the number of items sold during the quarter. Sales reached $4,847.80 million, representing 83.27% of the Group's total sales.
Sales of Government Pharma rose 7.15% to reach $201.63 million. This was mainly due to a higher participation in bidding processes during the quarter.
As a result, Government Pharma increased its participation with respect to total sales, from 3.24% in 3Q06 to 3.46% this quarter.
HEALTH, BEAUTY, CONSUMER GOODS, GENERAL MERCHANDISE AND OTHER
Sales in this division totaled $543.26 million during the quarter, an increase of 2.98% compared to 3Q06. The growth in this division was due to higher sales volume, which offset the decline in average unit prices during the period.
Citem's sales decreased 1.53% as a result of a lower average price and despite the fact that the number of items sold during the period increased approximately 10.10%.
Publications sales as a percentage of total sales declined from 4.01% in 3Q06 to 3.94% in the third quarter of 2007.
During the third quarter of the year, Grupo Casa Saba's gross income
grew 1.70% to reach $539.76 million. Despite the highly competitive
environment that has been discussed in previous reports, the Company was
able to increase its gross margin to 9.27% during the third quarter of
2007, which compares favorably to the margin of 9.1
|SOURCE Grupo Casa Saba, S.A.B. de C.V.|
Copyright©2007 PR Newswire.
All rights reserved